BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vattakatuchery JJ, Kurien R. Acetylcholinesterase inhibitors in cognitive impairment in Huntington’s disease: A brief review. World J Psychiatr 2013; 3(3): 62-64 [PMID: 24255877 DOI: 10.5498/wjp.v3.i3.62]
URL: https://www.wjgnet.com/2220-3206/full/v3/i3/62.htm
Number Citing Articles
1
Detlef Wietelmann. Neuropsychiatrische Störungen bei Chorea HuntingtonPSYCH up2date 2022; 16(06): 473 doi: 10.1055/a-1851-3700
2
Karen Ring, Robert O’Brien, Ningzhe Zhang, Lisa M. Ellerby. Patient-Specific Stem Cells2017; : 115 doi: 10.1201/9781315402185-7
3
Juan Manuel Orjuela-Rojas, Gustavo Adolfo Barrios Vincos, Melisa Alejandra Martínez Gallego. Neuropsiquiatría de los trastornos del movimientoRevista Colombiana de Psiquiatría 2017; 46: 59 doi: 10.1016/j.rcp.2017.05.010
4
Abhijit Dey, Banadipa Nanda, Samapika Nandy, Anuradha Mukherjee, Devendra Kumar Pandey. Bioactive Natural ProductsStudies in Natural Products Chemistry 2020; 67: 27 doi: 10.1016/B978-0-12-819483-6.00002-3
5
Abhijit Dey. Neuroprotective Natural Products2017; : 185 doi: 10.1002/9783527803781.ch8
6
Abhijit Dey, Jitendra Nath De. Neuroprotective therapeutics from botanicals and phytochemicals against Huntington's disease and related neurodegenerative disordersJournal of Herbal Medicine 2015; 5(1): 1 doi: 10.1016/j.hermed.2015.01.002
7
Pradeep Singh, Garima Mishra, Mulugeta Molla, Yohannes Shumet Yimer, Woretaw Sisay, Yared Andargie, Amien Ewunetie. Dietary and nutraceutical-based therapeutic approaches to combat the pathogenesis of Huntington’s diseaseJournal of Functional Foods 2022; 92: 105047 doi: 10.1016/j.jff.2022.105047
8
Ciaran M. Considine, M. Agustina Rossetti, Kendra Anderson, Victor A. Del Bene, Sharlet A. Anderson, Andrea S. Celka, Mary C. Edmondson, Amelia L. Nelson Sheese, Adam Piccolino, Antonio L. Teixeira, Julie C. Stout. Huntington study group’s neuropsychology working group position on best practice recommendations for the clinical neuropsychological evaluation of patients with Huntington diseaseThe Clinical Neuropsychologist 2024; 38(4): 984 doi: 10.1080/13854046.2023.2267789
9
Flavia Niccolini, Marios Politis. Neuroimaging in Huntington’s diseaseWorld Journal of Radiology 2014; 6(6): 301-312 doi: 10.4329/wjr.v6.i6.301
10
Sepideh Sadegh, James Skelton, Elisa Anastasi, Judith Bernett, David B. Blumenthal, Gihanna Galindez, Marisol Salgado-Albarrán, Olga Lazareva, Keith Flanagan, Simon Cockell, Cristian Nogales, Ana I. Casas, Harald H. H. W. Schmidt, Jan Baumbach, Anil Wipat, Tim Kacprowski. Network medicine for disease module identification and drug repurposing with the NeDRex platformNature Communications 2021; 12(1) doi: 10.1038/s41467-021-27138-2
11
Md. Rezaul Islam, Maruf Hossain Jony, Gazi Kaifeara Thufa, Shopnil Akash, Puja Sutra Dhar, Md. Mominur Rahman, Tahmina Afroz, Muniruddin Ahmed, Hassan A. Hemeg, Abdur Rauf, Muthu Thiruvengadam, Baskar Venkidasamy. A clinical study and future prospects for bioactive compounds and semi-synthetic molecules in the therapies for Huntington's diseaseMolecular Neurobiology 2024; 61(3): 1237 doi: 10.1007/s12035-023-03604-4
12
Kathleen M. Shannon, Avram Fraint. Therapeutic advances in Huntington's DiseaseMovement Disorders 2015; 30(11): 1539 doi: 10.1002/mds.26331
13
SKV Manjari, Sharon Mariam Abraham, R. Poornima, Rajneesh Kumar Chaturvedi, Shuvadeep Maity, Pragya Komal. Unprecedented effect of vitamin D3 on T-cell receptor beta subunit and alpha7 nicotinic acetylcholine receptor expression in a 3-nitropropionic acid induced mouse model of Huntington’s diseaseIBRO Neuroscience Reports 2023; 15: 116 doi: 10.1016/j.ibneur.2023.07.001
14
Samarpita Banerjee, Champa Keeya Tudu, Samapika Nandy, Devendra K. Pandey, Mimosa Ghorai, Mahipal S. Shekhawat, Arabinda Ghosh, Potshangbam Nongdam, Abdel R. Al-Tawaha, Ercan Bursal, Gaber E-S Batiha, Suchhanda Ghosh, Vinay Kumar, Abhijit Dey. Herbal Medicines2022; : 37 doi: 10.1016/B978-0-323-90572-5.00010-X
15
Tuulia Huhtala, Pekka Poutiainen, Jussi Rytkönen, Kimmo Lehtimäki, Teija Parkkari, Iiris Kasanen, Anu J. Airaksinen, Teija Koivula, Patrick Sweeney, Outi Kontkanen, John Wityak, Celia Dominiquez, Larry C. Park. Improved synthesis of [18F] fallypride and characterization of a Huntington’s disease mouse model, zQ175DN KI, using longitudinal PET imaging of D2/D3 receptorsEJNMMI Radiopharmacy and Chemistry 2019; 4(1) doi: 10.1186/s41181-019-0071-6